APA (7th ed.) Citation

A, R., ZC, W., I, G., CK, B., Y, S., C, B., . . . MA, P. (2026). CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis. Science translational medicine, 18(856), eadz3553. https://doi.org/10.1126/scitranslmed.adz3553

Chicago Style (17th ed.) Citation

A, Rampotas, et al. "CAR T Cell Therapy Selectively Depletes Disease-driving Mutant Calreticulin Cells in Xenotransplants and Human Organoid Models of Myelofibrosis." Science Translational Medicine 18, no. 856 (2026): eadz3553. https://doi.org/10.1126/scitranslmed.adz3553.

MLA (9th ed.) Citation

A, Rampotas, et al. "CAR T Cell Therapy Selectively Depletes Disease-driving Mutant Calreticulin Cells in Xenotransplants and Human Organoid Models of Myelofibrosis." Science Translational Medicine, vol. 18, no. 856, 2026, p. eadz3553, https://doi.org/10.1126/scitranslmed.adz3553.